Viromed Medical AGXTER:VME -1.39%22 Gross Margin % is 44.92% as of Dec. 2025, which is 365% above its 10-year median of 9.66. GuruFocus rates XTER:VME with a GF Score™ of 22/100. The stock has 5 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Viromed Medical AG ranks worse than 61.86% on this metric.
The historical rank and industry rank for Viromed Medical AG's Gross Margin % or its related term are showing as below:
XTER:VME'
s Gross Margin % Range Over the Past 10 Years
Min: -25.6 Med: 9.66 Max: 44.92
Current: 44.92
During the past 5 years, the highestGross Margin % of Viromed Medical AG was 44.92%. The lowest was -25.60%. And the median was 9.66%.
XTER:VME's Gross Margin % is ranked worse than 61.86% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 51.94
vs XTER:VME: 44.92
Viromed Medical AG had a gross margin of 44.92% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Viromed Medical AG was 0.00% per year.
Viromed Medical AG (XTER:VME) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Viromed Medical AG had a gross margin of 44.92% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Viromed Medical AG Gross Margin % Related Terms
Viromed Medical AG Gross Margin % Historical Data
* Premium members only.
The historical data trend for Viromed Medical AG's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTER:VME vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, Viromed Medical AG's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Viromed Medical AG Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Viromed Medical AG's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Viromed Medical AG's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Viromed Medical AG (XTER:VME) has a Gross Margin % of 44.92% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Viromed Medical AG and its competitors. This is 365% above median its historical median of 9.66. According to the industry distribution chart, Viromed Medical AG ranks #498 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 61.9%.
Is Viromed Medical AG's Gross Margin % too high?
Viromed Medical AG's current Gross Margin % of 44.92% is 365% above median its 10-year median of 9.66. The Medical Devices & Instruments industry median Gross Margin % is 51.94. Viromed Medical AG's value of 44.92% is 13.5% below this industry median. Based on the distribution chart, Viromed Medical AG ranks #498 out of 805 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Viromed Medical AG has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Viromed Medical AG's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Viromed Medical AG ranks #498 out of 805 companies for Gross Margin %. This places Viromed Medical AG in the lower half of its industry. The industry median Gross Margin % is 51.94. Viromed Medical AG's value of 44.92% is 13.5% below this benchmark. While the company's 10-year median is 9.66 vs. the industry median of 51.94, Viromed Medical AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 51.94, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Viromed Medical AG's current Gross Margin % of 44.92% is 13.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Viromed Medical AG and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 51.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Viromed Medical AG's current Gross Margin % is 44.92%, which is 365% above median its own 10-year median of 9.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viromed Medical AG stock overvalued right now?
Viromed Medical AG (XTER:VME) has a current Gross Margin % of 44.92%. The current Gross Margin % is 44.92%, which is 365% above median its 10-year median of 9.66 and 13.5% below the Medical Devices & Instruments industry median of 51.94. Viromed Medical AG's overall GF Score™ is 22/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Viromed Medical AG (XTER:VME), the current Gross Margin % is 44.92% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Viromed Medical AG is a medical technology company. It focuses on using cold plasma technology to develop medical solutions that protect people from viruses, bacteria, and multi-resistant germs. Viromed's product offerings include ViroCAP, a medical device based on cold plasma technology for treating wounds; ViroCAP derma-podo, a medical device that uses cold atmospheric plasma therapy for skin and foot care; and a Raumluftentkeimer. The company covers the entire value chain from research and development to production, logistics, marketing, and sales of its products.
22GF Score
Get the complete analysis for XTER:VME
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:VME has been successfully added to your 
